Final Results from PUNCH CD3-OLS, an Open-Label Clinical Trial of REBYOTA (Fecal Microbiota Live-jslm) in Patients with Recurrent C. Difficile Infection
Time: 9:30 am
day: Conference Day One
Details:
Download the Full Event Guide to see session details
